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Zinc is a critical regulator of 
placental morphogenesis and 
maternal hemodynamics during 
pregnancy in mice
Rebecca L. Wilson1,2, Shalem Y. Leemaqz1,2, Zona Goh1,3, Dale McAninch1,2, Tanja Jankovic-
Karasoulos1,2, Gabriela E. Leghi3, Jessica A. Phillips1,2, Katrina Mirabito Colafella4,5, Cuong 
Tran  6,7, Sean O’Leary1, Sam Buckberry8,9, Stephen Pederson10, Sarah A. Robertson1,2, Tina 
Bianco-Miotto  1,3 & Claire T. Roberts1,2
Zinc is an essential micronutrient in pregnancy and zinc deficiency impairs fetal growth. We used a 
mouse model of moderate zinc deficiency to investigate the physiological mechanisms by which zinc is 
important to placental morphogenesis and the maternal blood pressure changes during pregnancy. A 
26% reduction in circulating zinc (P = 0.005) was exhibited in mice fed a moderately zinc-deficient diet. 
Zinc deficiency in pregnancy resulted in an 8% reduction in both near term fetal and placental weights 
(both P < 0.0001) indicative of disrupted placental development and function. Detailed morphological 
analysis confirmed changes to the placental labyrinth microstructure. Continuous monitoring of 
maternal mean arterial pressure (MAP) revealed a late gestation decrease in the zinc-deficient 
dams. Differential expression of a number of regulatory genes within maternal kidneys supported 
observations on MAP changes in gestation. Increased MAP late in gestation is required to maintain 
perfusion of multiple placentas within rodent pregnancies. Decreased MAP within the zinc-deficient 
dams implies reduced blood flow and nutrient delivery to the placenta. These findings show that 
adequate zinc status is required for correct placental morphogenesis and appropriate maternal blood 
pressure adaptations to pregnancy. We conclude that insufficient maternal zinc intake from before and 
during pregnancy is likely to impact in utero programming of offspring growth and development largely 
through effects to the placenta and maternal cardiovascular system.
During pregnancy, the placental vasculature provides the interface between the fetus and the mother for exchange 
of nutrients and wastes. Adequate placental function underpins normal fetal development1. Defects in placental 
development and function are implicated in a number of clinical pregnancy complications. These include preec-
lampsia (PE)2, a common hypertensive disorder of pregnancy3 and fetal growth restriction (FGR)4–7, defined as 
birth weight, adjusted for gestational age, of ≤5th percentile3. Together these conditions pose a lifelong risk of 
morbidity and mortality for both the mother and infant. Increased placental oxidative stress is hypothesised to be 
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an underlying cause of pathogenesis in pregnancies complicated by PE and FGR8. While the precise mechanisms 
remain unclear, it is highly likely that micronutrient deficiencies play a pivotal role.
Zinc is extremely important during the accelerated fetal growth phase characteristic of late gestation. It is an 
essential element in more than 1000 proteins required for biological functions including antioxidant defence, 
cell signalling and gene expression9–12. In development, zinc is not only important for the action of transcription 
factors and the enzymes which catalyse the synthesis of DNA and RNA, but also as a component of the accessory 
proteins that regulate the activation of key development genes13. Increased fetal loss and high rates of congenital 
malformations in several organs of surviving fetuses are characteristics of severe zinc deficiency in pregnancy14,15. 
Compromised DNA integrity and increased oxidative stress are likely drivers of impaired tissue and physiological 
function when zinc intake is insufficient, since zinc is an essential component of copper-zinc superoxide dismu-
tase (Cu/Zn-SOD)16, and DNA-repair mechanisms such as p5317,18.
In rodents, maternal zinc deficiency consistently causes reduced fetal growth evident from mid-gestation 
to near term19–23. The mechanisms by which placental development and function contributes to impaired fetal 
growth in these models is largely unknown. Maternal hemodynamic adaptations to pregnancy are essential for 
optimal placental development and function, since adequate blood flow to the placenta underpins normal fetal 
growth24. Reduced uterine blood flow to the placenta not only constrains delivery of nutrients to the fetus and 
increases fetal hypoxia but also has implications for production of factors which modulate placental vascular 
growth25. We hypothesised that reduced fetal growth associated with maternal zinc deficiency is modulated by 
altered placental development and function and aimed to characterise the effect of moderate maternal zinc defi-
ciency on placental morphogenesis and maternal cardiovascular adaptations to pregnancy, in particular maternal 
blood pressure.
Results
Moderate Dietary Zinc Restriction Reduces Circulating Zinc and Liver Metallothionein 
Concentrations. To confirm that moderate dietary zinc restriction reduced maternal zinc status in C57BL/6 J 
female mice fed a zinc-deficient diet (containing 10 mg/kg zinc) compared to a zinc-replete diet (containing 
40 mg/kg zinc), we analysed maternal plasma zinc concentrations, liver metallothionein expression and placental 
and fetal zinc content. At gestational day (GD) 18.5, there was a 26% decrease in circulating zinc in the zinc-de-
ficient dams when compared to the zinc-replete dams (Fig. 1a; P = 0.005) and long term zinc status, as measured 
by liver metallothionein, was also reduced by 19% (Fig. 1b; P < 0.0001). There was no difference in maternal food 
consumption across the experimental period (mean 7 day food consumption per cage containing 4 mice (SEM) 
deficient: 92.4 (1.29) vs. replete: 90.6 (1.86) g; P = 0.45), confirming reduced zinc status was not a consequence 
of anorexia. Placental zinc concentrations remained similar between the two diet groups (Fig. 1c; P = 0.59) and 
there was a trend for an increase in zinc concentrations in fetuses from the zinc-deficient dams (Fig. 1d; P = 0.08), 
suggesting active mechanisms for sequestering zinc into gestational tissues. Circulating levels of phosphorus, 
sulphur and potassium were slightly higher in the zinc-deficient dams (Supplementary Table S1) but was likely 
due to minor differences in the diet compositions (Supplementary Table S2) and these nutrients did not differ in 
placental or fetal tissues (Supplementary Table S1).
Moderate Maternal Zinc Deficiency Impairs Fetal Growth. To investigate the impact of zinc defi-
ciency during pregnancy on placental development, we first compared reproductive outcomes in zinc-deficient 
and zinc-replete dams. At GD0.5 the zinc-deficient dams did not differ in weight compared to the zinc-replete 
dams (Fig. 2a; P = 0.24). However, at GD18.5 (24 hours before birth) they were 3% lighter compared to the 
zinc-replete (Fig. 2b; P = 0.044). The proportion of mated mice exhibiting viable pregnancies in late gestation 
was not different (data not shown), and litter size was not significantly different between the two diet groups 
(median [IQR] zinc-deficient: 7 [5, 8] vs. zinc-replete: 8 [6, 8.75]; P = 0.36), indicating no impact on fertility or 
fecundity. The lighter maternal body weight in the zinc-deficient dams was largely accounted for by an 8% reduc-
tion in both fetal and placental weights (Fig. 2c,d; both P < 0.0001) as maternal carcass weight (maternal weight 
minus fetal and placental weights combined) did not differ between the two diet groups (Fig. 2e; P = 0.24). The 
fetal-placental weight ratio did not significantly differ (Fig. 2f; P = 0.21), indicating similar nutrient transport 
efficiencies between the placentas. The importance of zinc to growth and development was highlighted in the 
postnatal phase, with pups from the zinc-deficient mothers 32% lighter at weaning compared to pups born to 
control dams (Supplementary Fig. S1). Survival rates to weaning were similar regardless of zinc status (survival at 
weaning; zinc-deficient: 30 out of 40 (75%) vs. zinc-replete: 20 out of 27 (74%); χ2 analysis; P = 1).
Effect of Maternal Zinc Deficiency on Placental Morphology. Having confirmed that moderate zinc 
deficiency in pregnancy resulted in reduced placental weight, we analysed placental morphology at GD18.5 as 
FGR is often associated with poor placental morphogenesis, and underpins future placental function26. Total 
placental mid-sagittal cross sectional area was not significantly different between the two diet groups despite 
a reduction in placental weight (median [IQR], deficient: 7.17 [5.88, 7.35] vs. replete: 6.71 [6.18, 7.01] mm2; 
P = 0.21). Furthermore, there was no difference in the mid-sagittal cross sectional area of the labyrinth zone; 
the region responsible for nutrient and waste exchange (Fig. 3a; P = 0.69), despite an 8% reduction in labyrinth 
zone weight in placentas from zinc-deficient dams (Fig. 3b, P = 0.012). This implied a disproportionate shift in 
placental architecture, as commonly occurs in an adaptive response to nutritional perturbation27, and was sup-
ported by detailed immunohistochemical (IHC) analysis. There are three main compartments which comprise 
the labyrinth zone; the fetal capillaries (FC: fetal circulation), maternal blood space (MBS: maternal circulation) 
and the trophoblasts which act as a barrier between the FC and MBS, to coordinate nutrient and waste exchange 
(Fig. 3c). In the placentas of zinc-deficient dams, both trophoblast volume and trophoblast barrier thickness were 
reduced by 16% (Fig. 3d,e; P = 0.007 and P = 0.016, respectively) there was a 17% increase in the volume density 
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of FC (Fig. 3f; P = 0.02) and 10% increase in surface area density (Fig. 3g; P = 0.028) compared to placentas from 
zinc-replete dams. Together these results indicate a compensatory mechanism in the zinc-deficient placentas that 
nevertheless was unable to rescue fetal growth.
Placental Iron Transport is Reduced by Zinc Deficiency. Zinc is extremely important in regulating 
the expression of a number of development genes crucial for fetal growth13. Conservation of zinc within the 
placentas and fetuses of the zinc-deficient dams suggested reduced zinc in the gestational tissues was not driv-
ing the reduction in fetal growth. A microarray analysis was used to identify pathways within the placenta that 
may be disrupted by maternal zinc deficiency however, only eight genes were identified to be potentially dif-
ferentially expressed (Supplementary Table S3). An 8.5-fold increase in the expression of Transferrin Receptor 
(Tfrc) in placentas from zinc-deficient dams was identified (Fig. 4a and Supplementary Table S3) and qPCR 
validation in an independent cohort of placentas confirmed an increase in gene expression (Fig. 4b; P < 0.0001). 
Furthermore, there was a 36% increase in the expression of Tfrc in maternal kidney tissue from the same cohort of 
mice (Fig. 4c; P = 0.019). IHC staining showed Tfrc protein localised to the apical surface of the trophoblast cells 
within the placental labyrinth (Fig. 4d) and Western blot analysis confirmed a 32% increase in protein expression 
in zinc-deficient placentas compared to zinc-replete (Fig. 4e and f; P = 0.022). Increased Tfrc expression was 
most likely a response to decreased placental and fetal iron concentration in the tissues from zinc-deficient dams 
(Supplementary Table S1). A 24% (P = 0.048) and 20% (P = 0.001) decrease in the zinc-deficient dams in placen-
tal and fetal iron, respectively, indicated disruption to placental iron transport despite maternal circulating iron 
remaining similar between the two diet groups (Table S1; P = 0.42). These data suggest a possible perturbation 
in the expression of Transferrin (Trf) protein which binds Tfrc to move predominantly iron into cells. However, 
using qPCR, we did not observe differential expression of Trf in either placentas or kidneys between the two diet 
groups (Fig. 4g and h; P = 0.12 and P = 0.82, respectively).
DNA Damage Caused by Oxidative Stress is Elevated by Zinc Deficiency. In vitro and in vivo mod-
els of both zinc and iron deficiency reveal increased oxidative stress and DNA damage28–32 as well as increased 
oxidative stress within the placenta in pregnancies complicated by FGR33,34. We investigated whether disrupted 
Figure 1. Lower zinc in the diets of the zinc-deficient mice reduced both short-term and long-term zinc 
stores. At GD18.5, a reduction in circulating zinc levels (a) as well as liver metallothionein (b) was observed 
in the zinc-deficient dams. Placental tissue zinc however remained similar between the two diet groups 
(c) and there was a trend for an increase in zinc content of fetuses from zinc-deficient dams (d). Data are 
median and interquartile range (n = 10 zinc-replete and 7 zinc-deficient [a & b] and n = 19 zinc-replete and 13 
zinc-deficient [c & d]). Statistical significance was determined using Mann-Whitney Test on data based on an 
average litter size of 7.00. *P < 0.05, #P = 0.08.
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placental function in this model of zinc deficiency was associated with increased oxidative stress. Placental 
expression of 4-hydroxynonenal (4HNE; a product of lipid peroxidation and marker of oxidative stress) was 
largely localized to the giant trophoblasts within the labyrinth zone (Fig. 5a) however, Western blot quantification 
of 4HNE expression revealed no difference in relative protein expression between placentas from zinc-deficient 
and zinc-replete dams (Fig. 5b; P = 0.72). There was also no difference in the expression of Cu/Zn-SOD between 
placentas from the two diet groups (Fig. 5c,d; P = 0.28). This indicates that neither increased lipid peroxidation 
nor reduced SOD expression was a characteristic of placental dysfunction in this model. However, increased 
DNA damage within the placental labyrinth zone in the placentas from the zinc-deficient dams as indicated by 
increased nuclei stained positively for 8-hydroxy-2′-deoxyguanosine (8-OHdG) (Fig. 5e,f; P < 0.0001) suggests 
Figure 2. Maternal zinc deficiency altered reproductive outcome, measured at GD18.5. No significant 
difference in maternal weight was observed between the zinc-replete and zinc-deficient dams at mating (a). At 
GD18.5, maternal weight of the zinc-deficient dams was reduced compared to the replete (b). This was largely 
due to a decrease in both fetal (c) and placental (d) weight as maternal carcass weight (e) was not significantly 
different. Placental efficiency, measured by the fetal-placental weight ratio was not different between the two 
diet groups (f). Data are median and interquartile range (n = 12 zinc-replete and 11 zinc-deficient). Statistical 
significance was determined using Mann-Whitney Test on data based on an average litter size of 7.00. *P < 0.05, 
***P < 0.001.
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Figure 3. Maternal zinc deficiency during pregnancy resulted in changes to the placental architecture likely 
to affect fetal growth. Despite no significant different in the labyrinth zone mid-sagittal cross sectional 
area (a), labyrinth zone weight was reduced in the zinc-deficient placentas at GD18.5 (b). Double labelling 
immunohistochemistry was used to identify the fetal capillaries (FC), trophoblasts (TB) and maternal blood 
space (MBS) within the labyrinth zone (c). Analysis revealed decreases in the trophoblast volume (d) as well as 
trophoblast barrier thickness (e) in the placentas from zinc-deficient dams. An increase in fetal capillary volume 
density (f) and surface volume (g) was also found. Data are median and interquartile range (n = 23 and 21 
placentas from 12 zinc-replete and 11 zinc-deficient dams, respectively). Statistical significance was determined 
using Mann-Whitney Test on data based on an average litter size of 7.00. *P < 0.05, **P < 0.01. GTB: giant 
trophoblast cells.
www.nature.com/scientificreports/
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a reduction in cellular integrity mediated by increased oxidative stress which would contribute to placental dys-
function. 8-OHdG staining was localised predominantly within giant trophoblasts as well as within glycogen cells 
present in the junctional zone.
Maternal Zinc Deficiency Alters Maternal Blood Pressure Profile During Pregnancy and Lactation. 
Adequate blood flow to the placenta is crucial for the maintenance of fetal growth and an exponential increase in 
placental blood flow is necessary for transport of oxygen, water and nutrients in late gestation25. Maternal cardi-
ovascular adaptations to pregnancy are crucial in maintaining appropriate placental blood flow so we sought to 
investigate whether zinc deficiency in pregnancy altered maternal blood pressure. Continuous measurements of 
mean arterial pressure (MAP), systolic blood pressure (SBP) and diastolic blood pressure (DBP) prior to preg-
nancy, within pregnancy and across lactation revealed that blood pressure was disturbed without adequate zinc 
intake (Fig. 6a and Supplementary Figure S2a). Across the five days prior to mating, average 24 h MAP was ele-
vated in the zinc-deficient dams compared to zinc-replete dams (Fig. 6a), driven by increased DBP during this 
period (Supplementary Fig. S2a). 24 h MAP, SPB and DBP were also elevated in the zinc-deficient dams during 
lactation. Within pregnancy, regardless of diet, MAP was different between days 11–19 of pregnancy compared 
to days 1–5. Between days 6–10 of pregnancy, 24 h MAP was elevated in the zinc-replete dams but decreased in 
deficient dams. This resulted in lower 24 h MAP between days 11–19 of pregnancy in the zinc-deficient dams 
compared to zinc-replete dams (Fig. 6a). Further analysis of diurnal MAP pattern during the day (0700 h–1850 h) 
and night (1900 h–0650 h) revealed differences in MAP during pregnancy were driven by differences in MAP 
Figure 4. Microarray analysis revealed an 8.5-fold increase in gene expression of transferrin receptor (Tfrc) 
in the placentas of the zinc-deficient dams (a). This increase was validated and confirmed in an independent 
cohort of placental samples using qPCR (b). qPCR was also used to measure Tfrc expression within kidney 
tissue at GD18.5 and was also increased in tissue collected from zinc-deficient dams (c). Immunohistochemical 
analysis of Tfrc protein showed localisation to the apical surface of the trophoblast cells within the labyrinth 
zone (LZ) of the placenta (d). Tfrc protein expression was analysed using Western blot and compared to β-actin 
expression (e); Tfrc band at ~100 kD and β-actin at ~42 kD, (full image in supplementary information). This 
revealed an increased expression of Tfrc protein in placentas from zinc-deficient dams (f). Transferrin (Trf) 
gene expression within the placenta and kidney was also quantified by qPCR but did not differ between the two 
diet groups (g,h). Data are median and interquartile range (n = 19 and 12 placentas [a]; 50 and 32 placentas [b 
and g]; 12 and 11 kidneys [c and h] and 12 and 10 placentas [e and f] from 12 zinc-replete and 11 zinc-deficient 
dams, respectively). Statistical significance was determined using Mann-Whitney Test. *P < 0.05, ***P < 0.001. 
JZ: junctional zone.
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during the day when mice are at rest and not during the night when mice are active (Supplementary Fig. S2b). 
Average 24 h pulse pressure; the difference between SBP and DBP, was lower in the zinc-deficient dams across 
the whole experimental period when compared to the zinc-replete dams (Fig. 6b). This, along with the fact that 
24 h heart rate (HR) was also decreased in the zinc-deficient dams (Supplementary Fig. S2c) indicates a potential 
reduction in cardiac output and reduced organ perfusion.
Maternal Zinc Deficiency Affects Renal Gene Expression and Structure. To investigate whether 
changes in maternal blood pressure late in gestation may be influenced by effects on aspects relating to renal 
function, we analysed kidney gene expression and morphology. qPCR analysis of kidney tissue at GD18.5 iden-
tified a number of differentially expressed genes in zinc-deficient and zinc-replete dams associated with blood 
pressure regulation (Supplementary Table S4). In particular, a 16% reduction in kidney expression of angiotensin 
converting enzyme (Ace) (P = 0.031) and a 44% reduction in inositol 1,4,5-triphosphate receptor type 2 (Itpr2) 
(P = 0.05) in the zinc-deficient dams occurred in association with reduced blood pressure observed at GD18.5 in 
mice implanted with blood pressure monitors. Ace protein expression in the kidneys was localised to the apical 
brush-borders of the proximal convoluted tubules and a 57% reduction in Ace protein expression in the kidneys 
Figure 5. Maternal zinc deficiency resulted in increased DNA damage caused by oxidative stress within the 
placenta at GD18.5. 4-hydoxynoneal (4HNE) expression was localisation to the glycogen cells (GC) present in 
the junctional zone (JZ) and giant trophoblast cells (GTB) within the labyrinth zone (LZ) of the placenta (a). 
Western blot analysis showed no difference in 4HNE expression between the two diet groups (b). Expression of 
Cu/Zn-Superoxide Dismutase (SOD) was found throughout the placenta (c) but expression was not different 
between placentas collected from a zinc-deficient or zinc-replete dams (d). 8-hydroxy-deoxyguanosine 
(8OHdG) was also expressed by the GTB cells and GC within the junctional zone (e). There was a statistically 
significant increase in the percentage of positive cells in the labyrinth zone of the placentas from zinc-deficient 
dams indicating an increase in DNA damage caused by oxidative stress (f). Data are median and interquartile 
range (n = 12 and 10 placentas [b] and 23 and 21 placentas [d & f] from 12 zinc-replete and 11 zinc-deficient 
dams, respectively). Statistical significance was determined using Mann-Whitney Test. *P < 0.05.
www.nature.com/scientificreports/
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of the zinc-deficient dams was demonstrated when compared to the zinc-replete dams (Fig. 7a–c; P < 0.01). Zinc 
deficiency also caused changes to glomerular morphology which can have implications for blood pressure. An 
11% reduction in glomeruli basement membrane (GBM) thickness was observed in the zinc-deficient dams, com-
pared to the zinc-replete dams at GD18.5 (Fig. 7d–f; P < 0.01), which would affect glomerular filtration capabili-
ties and therefore maternal blood pressure. Overall, this data is consistent with blood pressure measurements in 
late gestation. Given that placental blood flow is dependent upon maternal hemodynamic alterations across ges-
tation, the effects of zinc deficiency on maternal blood pressure are likely to contribute to placental dysfunction.
Maternal Zinc Deficiency Alters Immunological Parameters in Late Gestation. In addition to renal 
function, maternal blood pressure in pregnancy is influenced by immune cells, particularly T cells and natural 
killer (NK) cells35. These cells impact maternal hemodynamics and placental development by suppressing inflam-
matory mediators in the implantation site36 and promoting appropriate uterine vascular adaptation37. Spleen 
hypotrophy, as indicated by a 50% decrease in maternal spleen weight as a percentage of carcass weight, was 
observed in the zinc-deficient dams compared to zinc-replete dams at GD18.5 (Supplementary Fig. S3a; P = 0.01). 
There was also a significant reduction in liver, kidney and lung weights as a percentage of carcass weight in the 
zinc-deficient dams suggesting aberrant maternal adaptation to pregnancy (Supplementary Fig. S3b-d; P < 0.05 
for all). The failure to exhibit the spleen hypertrophy typical of late gestation38,39 is consistent with an impaired 
immune response to pregnancy. Histological analysis of the spleen at GD18.5 showed no difference in the percent-
age area of white pulp, the splenic region populated by lymphocytes, between the two diet groups (Supplementary 
Fig. S4a). However, there was a decrease in the absolute number of cells, calculated based on splenic weight, 
within the white pulp in the spleens of the zinc-deficient animals compared to the zinc-replete indicative of a 
reduced lymphocyte pool (Supplementary Fig. S4b; P = 0.051). We investigated changes to immune cell popula-
tions within the spleen at GD18.5 using qPCR to analyse marker genes and found a 41% reduction in the expres-
sion of Fasl, a marker expressed by activated T cells and NK cells and a 1.26-fold increase in the expression of 
Il10, which is expressed by regulatory T cells and type 2 T helper cells, in the zinc-deficient dams (Supplementary 
Fig. S5a,b; P = 0.043 for both, respectively). Furthermore, a trend toward elevated Ifna1 (Supplementary Fig. S5c; 
P = 0.07) expression was observed in the spleens of zinc-deficient dams compared to controls. This data indicates 
a possible imbalance in the residual lymphocyte subpopulations40 which would be expected to contribute to 
the cardiovascular and placental anomalies seen in the zinc-deficient dams. Maternal immune adaptations to 
Figure 6. Maternal zinc deficiency changed the blood and pulse pressure profiles of dams before pregnancy, 
during pregnancy and in lactation. Prior to pregnancy and during lactation, 24 hour mean arterial pressure 
(MAP) was significantly elevated in the zinc-deficient dams. (a) During pregnancy, from days GD0 to GD5, 
MAP was significantly elevated in the zinc-deficient dams. However, across GD6 to GD10, MAP began to 
decrease in the zinc-deficient dams while an increase was observed in the zinc-replete dams. This resulted in 
significantly lower MAP in the zinc-deficient dams between GD11 to GD19 of pregnancy. (b) Pulse pressure, 
which is the difference between systolic and diastolic blood pressures, was significantly lower in the zinc 
deficient animals across the whole experimental period. Each data point represents the average 24 h MAP or 
pulse pressure for each diet group ± SEM. n = 4 zinc-replete and 4 zinc-deficient dams. Statistical differences 
were determined using a general additive model.
www.nature.com/scientificreports/
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pregnancy are crucial to placental development during the implantation period and an altered immune balance 
may contribute to the mechanisms through which zinc deficiency disturbs placental morphogenesis and fetal 
growth.
Discussion
Correct placental morphogenesis underpins pregnancy success and offspring phenotype through tight regulation 
of transport of nutrients, gases and waste between the mother and fetus. This study confirms that maternal zinc 
status is a key determinant of fetal growth and shows that the effects of limited zinc are likely to be mediated 
through adverse placental development and function. Additionally, we show that altered placental development 
is associated with, and likely to be a consequence of, combined effects of altered maternal cardiovascular adap-
tations to pregnancy and altered renal function and immune changes. An interaction between zinc and other 
micronutrients within the placenta has also been identified, demonstrating the existence of micronutrient bio-
availability interactions within this complex physiological network.
Reduced fetal growth has been described in a number of rodent models assessing the effect of marginal and 
severe dietary zinc restriction during pregnancy19–23. In our model, reduced fetal growth at GD18.5 was asso-
ciated with an 8% reduction in placental weight, a common phenotype of growth restriction in humans and 
animals26,41. We sought to further investigate perturbations in placental development by defining impact on the 
placental architecture which regulates nutrient transport and fetal growth. A lower placental weight was reported 
at GD12.5 in a model of severe zinc restriction (<1 mg/kg)21. Unlike this earlier study, we did not observe a dif-
ference in labyrinth zone area at GD18.5 but IHC analysis of labyrinth zone composition demonstrated a change 
in placental structure indicative of a compensatory mechanism. Nutrients transfer from the maternal circulation 
to the fetus requires passage through a layer of trophoblast cells which surround the fetal capillaries42. Increases 
to the exchange surface area and the volume density of fetal capillaries, as well as decreases in the trophoblast 
Figure 7. Effects of marginal zinc deficiency on renal parameters at GD18.5. Decreased gene expression of 
angiotensin converting enzyme (Ace) was associated with a decrease in Ace protein expression within the kidneys 
of zinc-deficient dams (a). Representative image of Ace expression in a zinc-replete (b) and zinc-deficient  
(c) kidney section. Ace protein was localised to the proximal convoluted tubules (PCT). Marginal maternal zinc 
deficiency also decreased glomeruli basement membrane thickness (d). Representative images of a glomerulus 
in a zinc-replete (e) and zinc-deficient (f) kidney section. Data are median and interquartile range (n = 10 zinc-
replete and 9 zinc-deficient dams). Statistical significance was determined using Mann-Whitney Test. *P < 0.05, 
**P < 0.01. G: glomerulus. T: tubule
www.nature.com/scientificreports/
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barrier thickness of the zinc-deficient placentas suggest an increase in the transfer efficiency of nutrients per gram 
of placenta. However, the reduction in total placental size and thus labyrinthine volume is likely to elicit a greater 
effect on the transport of nutrients to the fetus than the difference in the magnitude of nutrient transfer per gram 
of placenta. This is supported by the observed similar placental efficiency between dietary zinc groups, as meas-
ured by the fetal-placental weight ratio, indicating these compensatory changes to the labyrinth zone structure 
are insufficient to rescue fetal growth.
The structure of the placenta at term is determined by events that occur much earlier in placental morpho-
genesis to drive differentiation of various trophoblast cell lineages and mesenchymal cells from stem cells in a 
defined stochastic relationship26,43. Alterations in gross placental structure as well as to the ultrastructure of the 
labyrinthine zone can confer either a functional advantage or disadvantage for nutrient transfer and fetal growth. 
Changes in developmental patterning that result in altered surface area, barrier thickness and fetal capillary vol-
ume can in part be influenced by the maternal immune adaptation to pregnancy, and the capacity of immune cells 
to support or limit early placental development44. Since the spleen is a key source of NK cells and T lymphocyte 
recruited into the uterine decidua and gestational tissues35, the reduced reservoir of splenic lymphocytes and 
the altered gene expression in spleen cells found in zinc-deficient females suggests that the immune response 
is aberrant in zinc-deficient mice. This is consistent with observations of the impact of zinc on T cell responses 
in non-pregnant animals45–47. Given the critical impacts of lymphocytes on maternal vascular remodeling and 
systemic cardiovascular adaptations to accommodate pregnancy35 the effects of zinc deficiency mediated via 
immune cells may contribute to placental dysmorphogenesis.
In pregnancy, placental function and the maternal circulatory system are intricately dependent upon one 
another. Perturbations in placental function are likely to influence the maternal circulation and vice-versa24. 
Increases in blood pressure late in gestation are a characteristic of rodent pregnancies as indicated by the blood 
pressure profile in the zinc-replete dams of this experiment and by others48. This presumably facilitates mainte-
nance of adequate perfusion of multiple placental beds as mice are litter-bearing species. Reduced uterine blood 
flow can also be used as a predictor of FGR in human pregnancies49,50 as transport of oxygen and nutrients needs 
to keep pace with fetal growth and this can only occur with adequate blood flow to the placenta. The decrease in 
blood pressure during late pregnancy, as well as reduced pulse pressure which was observed in the zinc-deficient 
dams is likely to result in reduced blood flow to the placenta, impairing nutrient delivery. The renin-angiotensin 
system (RAS) is one of the major physiological regulators of blood pressure mediated by the kidneys. Zinc is 
important to the function of a number of the RAS enzymes which catalyse the production of vasoconstrictors 
thereby increasing blood pressure51. Ace is a zinc metalloenzyme and chelation of zinc inhibits Ace function-
ality52. We also identified a reduction in Itpr2 expression which is a protein that controls vascular tone and is 
thought to alter the responsiveness of cells to components of the renin-angiotensin system53. These data support 
the importance of zinc in correct functioning of the RAS, particularly in the kidneys, and therefore blood pressure 
control which is necessary to maintain adequate placental perfusion and transplacental nutrient exchange.
Not only is blood flow a crucial determinant of placental function and fetal growth, but it also has implications 
for oxidative stress. Fluctuations in the perfusion of the placenta and therefore oxygenation is a major inducer of 
oxidative stress within the placenta which can severely affect placental transport capabilities54 and increased oxi-
dative stress has been characterised in the placenta of human pregnancies complicated by FGR33,34. Zinc itself is 
capable of acting as an antioxidant but is also required as a structural component of a number of first line defence 
antioxidant molecules55,56. Studies have shown that zinc deficiency leads to increased oxidative stress in vitro as 
well as in plasma of in vivo animal models28–30. Furthermore, zinc concentrations have also been shown to be 
positively correlated with superoxide dismutase concentrations in cord blood57. Zinc deficiency in this model did 
not increase the amount of lipid peroxidation within the placentas which is not entirely surprising as a similar 
result in human FGR placentas has been documented34,58 and may reflect the placenta’s ability to rapidly metab-
olise 4HNE59. Furthermore, there did not appear to be a disruption to the expression of Cu/Zn-SOD in the near 
term placenta. However, conservation of zinc within the gestational tissues may have ameliorated any effect on 
Cu/Zn-SOD expression or function characterised in other studies60,61. There was however, a significant elevation 
in DNA damage, particularly within the giant trophoblast cells present within the labyrinth zone of the placentas 
suggesting possible disruption to DNA repair mechanisms within these cells similar to that previously seen in cell 
culture models of zinc deficiency17,18. The giant trophoblast cells within the labyrinth zone function to produce 
hormones such as placental lactogen II and are positioned in order to facilitate delivery of hormones and nutri-
ents into the fetal circulation62,63. Consequently, increased DNA damage would likely reduce cellular integrity 
which could then effect aspects of giant trophoblast function and nutrient delivery, potentially amplifying already 
poor nutrient delivery from the maternal circulation resulting in fetal growth restriction.
There may also be a strong relationship between increased DNA damage in the placentas and the reduction 
of both placental and fetal iron in the zinc-deficient dams. Iron deficiency results in impaired mitochondrial 
function and increased oxidative stress in a number of different tissues31,32, hence it is reasonable to assume a 
reduction in placental iron is influencing oxidative stress pathways in a similar manner. Perturbed iron transport 
in the placentas also suggested a shift in iron transport out of the placenta occurring as part of a response to con-
serve zinc. Similar to our study, placental Tfrc expression has been shown to be inversely related to fetal liver iron 
concentrations64 suggesting a dialogue between the fetus and placenta which mediates iron transport. However, 
how this may be mediating zinc conservation within the gestational tissues - so why iron is reduced is unknown. 
Iron is known to be extremely important in supporting cell growth and metabolism65,66 and therefore reduced 
transport to the fetus would contribute to growth reduction. Previous studies have shown an accumulation of 
iron in tissues including the placenta and fetus in zinc deficient animal models67,68. The disparity with the current 
results likely reflects that previous studies utilised models of severe zinc restriction (˂0.5 mg/kg). Nevertheless, 
this new data further highlights a strong association between zinc and iron transport in the placenta worthy of 
further investigation.
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In conclusion, this study describes the effects of moderate maternal zinc deficiency on placental development 
and function, as well as responses of the maternal cardiovascular system to reduced zinc. Furthermore, the work 
implicates mechanistic pathways involving altered kidney and immune function by which inadequate zinc intake 
and stores during pregnancy impact on offspring phenotype. Zinc deficiency contributes substantially to the 
predicted 3.5 million deaths per year that are attributed to child and maternal undernutrition69. Reducing the 
prevalence of zinc deficiency in developing countries was a key aspect of the Millennium Development Goal 170. 
Our findings highlight the importance of adequate zinc status in pregnancy as deficiency impairs fetal growth. 
Since the trajectory of placental development is set in very early pregnancy, our data point to a need for further 
research to define the most critical window for zinc effects in pregnancy, and to develop strategies to reduce the 
impact of zinc deficiency in vulnerable women.
Material and Methods
Animals and diets. Seven-week-old C57Bl/6 J female mice (Laboratory Animal Services, University of 
Adelaide) were fed either a zinc replete diet containing 40 mg/kg zinc (Modified AIN93G, SF09-093; Specialty 
Feeds) or a marginally zinc deficient diet containing 10 mg/kg zinc (Zinc modified AIN93G, SF14-087; Specialty 
Feeds) as determined by inductively coupled plasma atomic emission spectrometry (ICP-MS). Animals were 
housed and maintained at Laboratory Animal Services, University of Adelaide on a 12 h: 12 h light-dark cycle 
with both water and food provided ad libitum. After six weeks on the respective diets, females were randomly 
allocated to either blood pressure monitoring by radio-telemetry (Cohort 1; n = 8) or analysis of placental and 
fetal growth (Cohort 2; n = 30). Mice in Cohort 2 were mated with a C57BL/6 J male fed standard chow (Specialty 
Feeds). The presence of a vaginal copulatory plug was designated gestational day 0.5 (GD0.5). Given the difficulty 
associated with implanting the radio-telemetry probe into very small mice, the mice in Cohort 1 were main-
tained on respective diets until 21 g (17-18 weeks-old), when radio-telemetry surgery was performed. All animals 
were maintained on diets until conclusion of experiments. Animal use complied with the Australian Code of 
Practice for the Care and Use of Animals and ethics approval was obtained from the University of Adelaide Ethics 
Committee (Approval #M-2014-84).
Elemental Analysis. Elemental analysis on maternal plasma, placental and fetal tissues was undertaken 
to determine the effect of dietary zinc restriction on calcium, potassium, magnesium, sodium, sulphur and 
phosphorus, determined using inductively-coupled plasma optical emission spectrometry (ICP-OES) (Agilent 
5100 ICP-OES; CSIRO Analytical Services, South Australia) and zinc, iron, copper, and selenium determined 
by ICP-MS (Agilent 7700 ICP-MS). Details of the sample preparation procedure are provided in Supplementary 
Materials and Methods. Disruptions to long term zinc stores were analysed by measuring liver metallothionein at 
GD18.5 and 21 days post-birth using a 109Cd/heme affinity assay71.
Placental and Fetal Characteristics. Post-mortem was performed on the dams in cohort 2 between 
1000–1200 h on GD18.5, described in full in Supplementary Materials and Methods. Maternal, placental and fetal 
tissue was collected and the number of total, viable and resorbing implantation sites was counted. From each 
dam, 2 placentas were fixed and 5 µm thickness full-face sections were stained with Masson’s Trichrome following 
standard protocols in order to determine the mid sagittal total, labyrinth zone and junctional zone cross sectional 
areas. In depth analysis of labyrinth structure was performed using immunohistochemistry (IHC) as previously 
described72,73 and details of antibodies and dilutions used are provided in Supplementary Table S5. Microarray, 
qPCR, IHC and Western blot analysis were employed to analyse gene and protein parameters and are detailed in 
Supplementary Materials and Methods. Microarray data have been deposited to NCBI GEO under the accession 
GSE97112.
Radio-telemetry surgery, blood pressure monitoring and kidney analysis. Dams in cohort 1 
were anaesthetised (2.5% isofluorane and 1 L/minute O2, then maintained at 1.5% isofluorane and ½ L/min-
ute O2; AttaneTM Isoflurane, Bomac) and a radio-telemetry probe (PAC10, Data Sciences International) was 
inserted into the left carotid artery. The probe body was placed subcutaneously on the right flank. Mice recov-
ered for 10 days, then MAP and HR were monitored for 10 seconds every 10 minutes for 5 days prior to the 
dams being placed with males. The presence of a copulatory plug designated GD0.5 and MAP and HR contin-
ued to be measured through pregnancy, birth and lactation. Pups were counted on the day of birth and weighed 
at 3, 5 and 7 days post-birth and at weaning. 21 days post-birth, dams and pups were killed and post-mortems 
performed between 1000–1200 h to collect maternal and pup tissues as described in Supplementary Materials 
and Methods.
To further investigate the effects of zinc deficiency on maternal blood pressure, the left kidney was fixed as per 
the protocol outlined in Supplementary Materials and Methods. The right kidney was snap-frozen for molecular 
analyses. 5 µm full-faced, mid-sagittal sections were stained using Masson’s Trichrome in order to determine the 
cortex and medullary zone area. Picrosirius red staining was used to determine collagen deposition and Jones’ 
membrane staining was used to assess glomeruli morphology. In order to understand effects on aspects of renal 
function, 91 genes known to be associated with blood pressure regulation were analysed using qPCR. The staining 
procedures as well as details of qPCR gene expression analysis, IHC and Western blot analysis of protein expres-
sion are detailed in Supplementary Materials and Methods.
Statistics. All statistical analysis was performed in R (v3.1.1)74 using Mann-Whitney Test unless otherwise 
specified. Maternal organ weights, fetal and placental weight were corrected for viable litter size using the lme 
function in the nlme package to generate predicted values based on an average litter size of 7, then Mann-Whitney 
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test was used to calculate exact P-values based on the predicted results. Significant differences in 24 h MAP and 
HR between the two diet groups were determined using a generalized additive mixed-model, as detailed in 
Supplementary Materials and Methods. Results are reported as median and interquartile range unless otherwise 
stated.
Data Availability. Microarray data have been deposited to NCBI GEO under the accession GSE97112.
References
 1. Cross, J. C. Formation of the placenta and extraembryonic membranes. Annals of the New York Academy of Sciences 857, 23–32 
(1998).
 2. Ma, Y., Shen, X. & Zhang, D. The Relationship between Serum Zinc Level and Preeclampsia: A Meta-Analysis. Nutrients 7, 
7806–7820, https://doi.org/10.3390/nu7095366 (2015).
 3. Tranquilli, A. L. et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: A revised statement 
from the ISSHP. Pregnancy Hypertens 4, 97–104, https://doi.org/10.1016/j.preghy.2014.02.001 (2014).
 4. Abass, R. M. et al. Zinc and copper levels in low birth weight deliveries in MedaniHospital, Sudan. BMC Res Notes 7, 386, https://doi.
org/10.1186/1756-0500-7-386 (2014).
 5. Negandhi, P. H., Negandhi, H. N., Zodpey, S. P., Ughade, S. N. & Biranjan, J. R. Risk factors for low birth weight in an Indian urban 
setting: a nested case control study. Asia Pac J Public Health 26, 461–469, https://doi.org/10.1177/1010539511431486 (2014).
 6. Rwebembera, A. A.-B., Munubhi, E. K. D., Manji, K. P., Mpembeni, R. & Philip, J. Relationship between infant birth weight 
</= 2000 g and maternal zinc levels at Muhimbili National Hospital, Dar Es Salaam, Tanzania. J Trop Pediatr 52, 118–125 (2006).
 7. Borella, P. et al. Maternal plasma concentrations of magnesium, calcium, zinc and copper in normal and pathological pregnancies. 
Sci Total Environ 99, 67–76 (1990).
 8. Burton, G. J. & Jauniaux, E. Placental oxidative stress: from miscarriage to preeclampsia. Journal of the Society for Gynecologic 
Investigation 11, 342–352, https://doi.org/10.1016/j.jsgi.2004.03.003 (2004).
 9. Prasad, A. S. Clinical, immunological, anti-inflammatory and antioxidant roles of zinc. Experimental gerontology 43, 370–377, 
https://doi.org/10.1016/j.exger.2007.10.013 (2008).
 10. MacDonald, R. S. The role of zinc in growth and cell proliferation. The Journal of nutrition 130, 1500s–1508s (2000).
 11. Cousins, R. Zinc In, Bowman BA, Russell RM. Present Knowledge in Nutrition. Washington, DC ILSI Press 9, 445–457 (2006).
 12. Maret, W. Molecular aspects of human cellular zinc homeostasis: redox control of zinc potentials and zinc signals. Biometals 22, 
149–157 (2009).
 13. Vallee, B. L. & Falchuk, K. H. The biochemical basis of zinc physiology. Physiol Rev 73, 79–118 (1993).
 14. Hurley, L. S. & Mutch, P. B. Prenatal and postnatal development after transitory gestational zinc deficiency in rats. The Journal of 
nutrition 103, 649–656 (1973).
 15. Uriu-Adams, J. Y. & Keen, C. L. Zinc and reproduction: effects of zinc deficiency on prenatal and early postnatal development. Birth 
Defects Res B Dev Reprod Toxicol 89, 313–325, https://doi.org/10.1002/bdrb.20264 (2010).
 16. Yim, M. B., Chock, P. B. & Stadtman, E. R. Copper, zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen 
peroxide. Proc Natl Acad Sci USA 87, 5006–5010 (1990).
 17. Fanzo, J. C. et al. Zinc status affectsp53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells. Am 
J Physiol Cell Physiol 281, C751–757 (2001).
 18. Ho, E. & Ames, B. N. Low intracellular zinc induces oxidative DNA damage, disruptsp53, NFkappa B, and AP1 DNA binding, and 
affects DNA repair in a rat glioma cell line. Proc Natl Acad Sci USA 99, 16770–16775, https://doi.org/10.1073/pnas.222679399 
(2002).
 19. Tomat, A. et al. Exposure to zinc deficiency in fetal and postnatal life determines nitric oxide system activity and arterial blood 
pressure levels in adult rats. The British journal of nutrition 104, 382–389, https://doi.org/10.1017/s0007114510000759 (2010).
 20. Kim, J. T. et al. Zinc-deficient diet decreases fetal long bone growth through decreased bone matrix formation in mice. Journal of 
medicinal food 12, 118–123, https://doi.org/10.1089/jmf.2007.0647 (2009).
 21. Tian, X., Anthony, K., Neuberger, T. & Diaz, F. J. Preconception Zinc Deficiency Disrupts Postimplantation Fetal and Placental 
Development in Mice. Biology of reproduction, https://doi.org/10.1095/biolreprod.113.113910 (2014).
 22. Ueda, H. et al. Effects of zinc deficiency and supplementation on leptin and leptin receptor expression in pregnant mice. Biological & 
pharmaceutical bulletin 37, 581–587 (2014).
 23. Padmavathi, I. J. et al. Prenatal and perinatal zinc restriction: effects on body composition, glucose tolerance and insulin response in 
rat offspring. Experimental physiology 94, 761–769, https://doi.org/10.1113/expphysiol.2008.045856 (2009).
 24. Reynolds, L. P. et al. Uteroplacental vascular development and placental function: an update. Int J Dev Biol 54, 355–366, https://doi.
org/10.1387/ijdb.082799lr (2010).
 25. Reynolds, L. P. et al. Evidence for altered placental blood flow and vascularity in compromised pregnancies. J Physiol 572, 51–58, 
https://doi.org/10.1113/jphysiol.2005.104430 (2006).
 26. Fowden, A. L., Ward, J. W., Wooding, F. P., Forhead, A. J. & Constancia, M. Programming placental nutrient transport capacity. J 
Physiol 572, 5–15, https://doi.org/10.1113/jphysiol.2005.104141 (2006).
 27. Burton, G. J. & Fowden, A. L. Review: The placenta and developmental programming: balancing fetal nutrient demands with 
maternal resource allocation. Placenta 33(Suppl), S23–27, https://doi.org/10.1016/j.placenta.2011.11.013 (2012).
 28. Kawasaki, I., Suzuki, Y. & Yanagisawa, H. Zinc deficiency enhances the induction of micronuclei and 8-hydroxy-2′-deoxyguanosine 
via superoxide radical in bone marrow of zinc-deficient rats. Biological trace element research 154, 120–126, https://doi.org/10.1007/
s12011-013-9706-8 (2013).
 29. Prasad, A. S., Bao, B., Beck, F. W. & Sarkar, F. H. Zinc-suppressed inflammatory cytokines by induction of A20-mediated inhibition 
of nuclear factor-kappaB. Nutrition 27, 816–823, https://doi.org/10.1016/j.nut.2010.08.010 (2011).
 30. Song, Y., Leonard, S. W., Traber, M. G. & Ho, E. Zinc deficiency affects DNA damage, oxidative stress, antioxidant defenses, and 
DNA repair in rats. The Journal of nutrition 139, 1626–1631, https://doi.org/10.3945/jn.109.106369 (2009).
 31. Knutson, M. D., Walter, P. B., Ames, B. N. & Viteri, F. E. Both iron deficiency and daily iron supplements increase lipid peroxidation 
in rats. The Journal of nutrition 130, 621–628 (2000).
 32. Walter, P. B. et al. Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats. Proc Natl Acad Sci USA 99, 
2264–2269, https://doi.org/10.1073/pnas.261708798 (2002).
 33. Biri, A. et al. Role of oxidative stress in intrauterine growth restriction. Gynecologic and obstetric investigation 64, 187–192, https://
doi.org/10.1159/000106488 (2007).
 34. Takagi, Y. et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. 
Virchows Arch 444, 49–55, https://doi.org/10.1007/s00428-003-0903-2 (2004).
 35. Burke, S. D. et al. Cardiovascular adaptations of pregnancy in T and B cell-deficient mice. Biology of reproduction 85, 605–614, 
https://doi.org/10.1095/biolreprod.111.092668 (2011).
 36. Robertson, S. A. & Moldenhauer, L. M. Immunological determinants of implantation success. Int J Dev Biol 58, 205–217, https://doi.
org/10.1387/ijdb.140096sr (2014).
www.nature.com/scientificreports/
13SCiEntifiC RePORts | 7: 15137  | DOI:10.1038/s41598-017-15085-2
 37. Madeja, Z. et al. Paternal MHC expression on mouse trophoblast affects uterine vascularization and fetal growth. Proc Natl Acad Sci 
USA 108, 4012–4017, https://doi.org/10.1073/pnas.1005342108 (2011).
 38. Mattsson, R., Nilsson, B. & Lindahl-Kiessling, K. An investigation of splenic enlargement in pregnant mice. Dev Comp Immunol 3, 
683–695 (1979).
 39. Norton, M. T., Fortner, K. A., Bizargity, P. & Bonney, E. A. Pregnancy alters the proliferation and apoptosis of mouse splenic 
erythroid lineage cells and leukocytes. Biology of reproduction 81, 457–464, https://doi.org/10.1095/biolreprod.109.076976 (2009).
 40. Sallusto, F., Geginat, J. & Lanzavecchia, A. Central memory and effector memory T cell subsets: function, generation, and 
maintenance. Annu. Rev. Immunol. 22, 745–763 (2004).
 41. Mayhew, T. M. et al. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and 
without intrauterine growth restriction. Placenta 24, 219–226 (2003).
 42. Georgiades, P., Ferguson-Smith, A. & Burton, G. Comparative developmental anatomy of the murine and human definitive 
placentae. Placenta 23, 3–19 (2002).
 43. Sferruzzi-Perri, A. N. & Camm, E. J. The Programming Power of the Placenta. Front Physiol 7, 33, https://doi.org/10.3389/
fphys.2016.00033 (2016).
 44. Robertson, S. A., Petroff, M. & Hunt, J. S. In Knobil and Neill’s physiology of reproduction Vol. 2 (eds T. M. Plant & A. Zeleznik) Ch. 
41, 1835–1874 (Elsiver, 2014).
 45. Fernandes, G. et al. Impairment of cell-mediated immunity functions by dietary zinc deficiency in mice. Proc Natl Acad Sci USA 76, 
457–461 (1979).
 46. Hosea Blewett, H. J., Rector, E. S. & Taylor, C. G. Altered ex vivo cytokine production in zinc-deficient, pair-fed and marginally zinc-
deficient growing rats is independent of serum corticosterone concentrations. The British journal of nutrition 100, 820–828, https://
doi.org/10.1017/s0007114508942148 (2008).
 47. Hosea, H. J., Rector, E. S. & Taylor, C. G. Dietary repletion can replenish reduced T cell subset numbers and lymphoid organ weight 
in zinc-deficient and energy-restricted rats. The British journal of nutrition 91, 741–747, https://doi.org/10.1079/bjn20041104 
(2004).
 48. Mirabito, K. M. et al. Role of Inflammation and the Angiotensin Type 2 Receptor in the Regulation of Arterial Pressure During 
Pregnancy in Mice. Hypertension, https://doi.org/10.1161/hypertensionaha.114.03189 (2014).
 49. North, R. A., Ferrier, C., Long, D., Townend, K. & Kincaid-Smith, P. Uterine artery Doppler flow velocity waveforms in the second 
trimester for the prediction of preeclampsia and fetal growth retardation. Obstetrics and gynecology 83, 378–386 (1994).
 50. Trudinger, B. J. & Cook, C. M. Umbilical and uterine artery flow velocity waveforms in pregnancy associated with major fetal 
abnormality. Br J Obstet Gynaecol 92, 666–670 (1985).
 51. Vallotton, M. The renin-angiotensin system. Trends in Pharmacological Sciences 8, 69–74 (1987).
 52. Bunning, P. & Riordan, J. F. The functional role of zinc in angiotensin converting enzyme: implications for the enzyme mechanism. 
Journal of inorganic biochemistry 24, 183–198 (1985).
 53. Wilker, E. et al. Postural changes in blood pressure associated with interactions between candidate genes for chronic respiratory 
diseases and exposure to particulate matter. Environmental health perspectives 117, 935–940, https://doi.org/10.1289/ehp.0800279 
(2009).
 54. Cindrova-Davies, T., Spasic-Boskovic, O., Jauniaux, E., Charnock-Jones, D. S. & Burton, G. J. Nuclear factor-kappa B, p38, and 
stress-activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and 
apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 170, 1511–1520, 
https://doi.org/10.2353/ajpath.2007.061035 (2007).
 55. Marklund, S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. 
Acta physiologica Scandinavica. Supplementum 492, 19–23 (1980).
 56. Maret, W. Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Experimental gerontology 43, 
363–369, https://doi.org/10.1016/j.exger.2007.11.005 (2008).
 57. Negi, R. et al. Trace elements and antioxidant enzymes associated with oxidative stress in the pre-eclamptic/eclamptic mothers 
during fetal circulation. Clin Nutr 31, 946–950, https://doi.org/10.1016/j.clnu.2012.04.005 (2012).
 58. Santoso, D. I. et al. Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and pre-eclamptic placentae. 
Placenta 23, 373–379, https://doi.org/10.1053/plac.2002.0818 (2002).
 59. Hnat, M. D. et al. Heat shock protein-70 and 4-hydroxy-2-nonenal adducts in human placental villous tissue of normotensive, 
preeclamptic and intrauterine growth restricted pregnancies. American journal of obstetrics and gynecology 193, 836–840, https://
doi.org/10.1016/j.ajog.2005.01.059 (2005).
 60. Knoell, D. L. et al. Zinc deficiency increases organ damage and mortality in a murine model of polymicrobial sepsis. Crit Care Med 
37, 1380–1388, https://doi.org/10.1097/CCM.0b013e31819cefe4 (2009).
 61. Suzuki, T., Katsumata, S., Matsuzaki, H. & Suzuki, K. Dietary zinc deficiency induces oxidative stress and promotes tumor necrosis 
factor-alpha- and interleukin-1beta-induced RANKL expression in rat bone. J Clin Biochem Nutr 58, 122–129, https://doi.
org/10.3164/jcbn.15-87 (2016).
 62. Simmons, D. G., Fortier, A. L. & Cross, J. C. Diverse subtypes and developmental origins of trophoblast giant cells in the mouse 
placenta. Dev Biol 304, 567–578, https://doi.org/10.1016/j.ydbio.2007.01.009 (2007).
 63. Simmons, D. G. et al. Early patterning of the chorion leads to the trilaminar trophoblast cell structure in the placental labyrinth. 
Development 135, 2083–2091, https://doi.org/10.1242/dev.020099 (2008).
 64. Gambling, L. et al. Fetal iron status regulates maternal iron metabolism during pregnancy in the rat. Am J Physiol Regul Integr Comp 
Physiol 296, R1063–1070, https://doi.org/10.1152/ajpregu.90793.2008 (2009).
 65. Le, N. T. & Richardson, D. R. The role of iron in cell cycle progression and the proliferation of neoplastic cells. Biochimica et 
biophysica acta 1603, 31–46 (2002).
 66. Pourcelot, E. et al. Iron for proliferation of cell lines and hematopoietic progenitors: Nailing down the intracellular functional iron 
concentration. Biochimica et biophysica acta 1853, 1596–1605, https://doi.org/10.1016/j.bbamcr.2015.03.009 (2015).
 67. Reinstein, N. H., Lonnerdal, B., Keen, C. L. & Hurley, L. S. Zinc-copper interactions in the pregnant rat: fetal outcome and maternal 
and fetal zinc, copper and iron. The Journal of nutrition 114, 1266–1279 (1984).
 68. Rogers, J. M., Lonnerdal, B., Hurley, L. S. & Keen, C. L. Iron and zinc concentrations and 59Fe retention in developing fetuses of 
zinc-deficient rats. The Journal of nutrition 117, 1875–1882 (1987).
 69. Black, R. E. et al. Maternal and child undernutrition: global and regional exposures and health consequences. Lancet 371, 243–260, 
https://doi.org/10.1016/s0140-6736(07)61690-0 (2008).
 70. Organisation, W. H. Fact Sheet No 290 - Millennium Development Goals (MDGs), <http://www.who.int/mediacentre/factsheets/
fs290/en/#> (2015).
 71. Eaton, D. L. & Toal, B. F. Evaluation of the Cd/hemoglobin affinity assay for the rapid determination of metallothionein in biological 
tissues. Toxicol Appl Pharmacol 66, 134–142 (1982).
 72. Roberts, C. T., White, C. A., Wiemer, N. G., Ramsay, A. & Robertson, S. A. Altered placental development in interleukin-10 null 
mutant mice. Placenta 24(Suppl A), S94–99 (2003).
 73. Wilson, R. L. et al. Vitamin D Receptor Gene Ablation in the Conceptus Has Limited Effects on Placental Morphology, Function and 
Pregnancy Outcome. PloS one 10, e0131287, https://doi.org/10.1371/journal.pone.0131287 (2015).
 74. R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2011).
www.nature.com/scientificreports/
1 4SCiEntifiC RePORts | 7: 15137  | DOI:10.1038/s41598-017-15085-2
Acknowledgements
We thank the staff at Laboratory Animal Services, University of Adelaide for their assistance in maintaining 
the animals. This work was funded in part by, the National Health and Medical Research Council of Australia 
(NHMRC) Project Grant (GNT1020754) awarded to C.T.R. C.T.R. is supported by a Lloyd Cox Professorial 
Research Fellowship. S.B. is supported by an NHMRC-ARC Dementia Research Development Fellowship Grant 
GNT1111206. K.M.C. is supported by an NHMRC Fellowship Grant GNT 1112125. R.L.W. is supported by an 
Australian Postgraduate Award.
Author Contributions
R.L.W., S.O.L., T.B.M. and C.T.R. conceived the experimental design. R.L.W., Z.G., D.M., T.J.K., J.A.P., K.M.C. 
and C.T. performed the experiments. R.L.W., S.Y.L. and G.E.L. analysed the results and performed the statistics. 
S.B. and S.P. analysed the microarray data. S.A.R., T.B.M. and C.T.R. supervised the work. R.L.W. wrote the 
manuscript. All authors edited and reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-017-15085-2.
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
